S. S. Chugh, R. Havmoeller, and K. Narayanan, Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease, Study. Circulation, vol.129, pp.837-884, 2010.

D. A. Lane, F. Skjøth, and G. Lip, Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care, J Am Heart Assoc, vol.6, p.5155, 2017.

A. Charlemagne, J. Blacher, and A. Cohen, Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data, Arch Cardiovasc Dis, vol.104, pp.115-139, 2011.

S. Stewart, C. L. Hart, and D. J. Hole, A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study, Am J Med, vol.113, pp.359-64, 2002.

I. Marzona, M. O'donnell, and K. Teo, Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies, Can Med Assoc J, vol.184, pp.329-365, 2012.

L. Friberg, M. Rosenqvist, and G. Lip, Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study, Eur Heart J, vol.33, pp.1500-1510, 2012.

R. A. Grimm, W. J. Stewart, and I. W. Black, Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation?, J Am Coll Cardiol, vol.23, pp.533-574, 1994.

R. Beigel, N. C. Wunderlich, and S. Y. Ho, The Left Atrial Appendage: Anatomy, Function, and Noninvasive Evaluation, JACC Cardiovasc Imaging, vol.7, pp.1251-65, 2014.

J. L. Blackshear and J. A. Odell, Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation, Ann Thorac Surg, vol.61, issue.95, p.887, 1996.

P. Kirchhof, S. Benussi, and D. Kotecha, ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, vol.37, pp.2893-962, 2016.

R. M. Melduni, H. V. Schaff, and H. Lee, Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score-Matched Analysis of 10 633 Patients, Circulation, vol.135, pp.366-78, 2017.

R. Whitlock, J. Healey, and J. Vincent, Rationale and design of the Left Atrial Appendage Occlusion Study, Ann Cardiothorac Surg, vol.3, p.11, 2014.

D. R. Holmes, V. Y. Reddy, and Z. G. Turi, Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial, Lancet, vol.374, p.9, 2009.

D. R. Holmes, S. Kar, and M. J. Price, Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy, J Am Coll Cardiol, vol.64, pp.1-12, 2014.

L. V. Boersma, H. Ince, and S. Kische, Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage, Circ Arrhythm Electrophysiol, vol.12, p.6841, 2019.

M. Glikson, R. Wolff, and G. Hindricks, EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion -an update, EuroIntervention, vol.15, pp.1133-1180, 2020.

Z. Jalal, M. L. Dinet, and N. Combes, Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short-and mid-term outcomes, Arch Cardiovasc Dis, vol.110, pp.242-251, 2017.

P. Merella, G. Lorenzoni, and A. P. Delitala, Left Atrial Appendage Occlusion in High Bleeding Risk Patients, J Interv Cardiol, p.6704031, 2019.

K. Korsholm, K. Nielsen, and J. Jensen, Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for postimplant antithrombotic therapy, EuroIntervention, vol.12, pp.2075-82, 2017.

D. A. Lane, F. Skjøth, and G. Lip, Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care, J Am Heart Assoc, vol.6, p.5155, 2017.

P. Kirchhof, S. Benussi, and D. Kotecha, ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, vol.37, pp.2893-962, 2016.

D. R. Holmes, V. Y. Reddy, and Z. G. Turi, Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial, Lancet, vol.374, p.61343, 2009.

D. R. Holmes, S. Kar, and M. J. Price, Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy, J Am Coll Cardiol, vol.64, pp.1-12, 2014.

L. V. Boersma, H. Ince, and S. Kische, Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage, Circ Arrhythm Electrophysiol, vol.12, p.6841, 2019.

M. Glikson, R. Wolff, and G. Hindricks, EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion -an update, EuroIntervention, vol.15, pp.1133-80, 2020.

A. Tzikas, D. R. Holmes, and S. Gafoor, Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies, EuroIntervention, vol.12, pp.103-114, 2016.

L. V. Boersma, H. Ince, and S. Kische, Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial, Heart Rhythm, vol.14, pp.1302-1310, 2017.

J. Brachmann, T. Lewalter, and I. Akin, Interventional occlusion of left atrial appendage in patients with atrial fibrillation, J Interv Card Electrophysiol Published Online First, 2019.

M. W. Bergmann, H. Ince, and S. Kische, Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study, EuroIntervention, vol.13, pp.2003-2014, 2018.

L. Fauchier, A. Cinaud, and P. Defaye, Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation, J Am Coll Cardiol, vol.71, pp.1528-1564, 2018.

K. Korsholm, K. Nielsen, and J. Jensen, Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for postimplant antithrombotic therapy, EuroIntervention, vol.12, pp.2075-82, 2017.

P. Merella, G. Lorenzoni, and A. P. Delitala, Left Atrial Appendage Occlusion in High Bleeding Risk Patients, J Interv Cardiol, p.6704031, 2019.

Z. Jalal, M. L. Dinet, and N. Combes, Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short-and mid-term outcomes, Arch Cardiovasc Dis, vol.110, pp.242-251, 2017.

M. Lempereur, A. Aminian, and X. Freixa, Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet: Device-Related Thrombosis After LAAO, Catheter Cardio Inte, vol.90, pp.111-132, 2017.

L. Søndergaard, Y. H. Wong, and V. Y. Reddy, Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN, JACC-Cardiovasc Inte, vol.12, pp.1055-63, 2019.

S. R. Dukkipati, S. Kar, and D. R. Holmes, Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes, Circulation, vol.138, pp.874-85, 2018.

G. Lip, L. Frison, and J. L. Halperin, Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation, J Am Coll Cardiol, vol.57, pp.173-80, 2011.

L. Friberg, M. Rosenqvist, and G. Lip, Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study, Eur Heart J, vol.33, pp.1500-1510, 2012.

J. P. Pouru, S. Jaakkola, and J. Lund, Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure, Am J Cardiol, vol.124, pp.1894-1903, 2019.

F. K. Weise, S. Bordignon, and L. Perrotta, Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices, EuroIntervention, vol.13, pp.2138-2184, 2018.

D. Hildick-smith, U. Landmesser, and A. J. Camm, Left atrial appendage occlusion with the AmplatzerTM AmuletTM device: full results of the prospective global observational study, Eur Heart J, vol.169, pp.1-8, 2020.